🇲🇾 NPRA — Pusat Kawalan Kualiti · ISO/IEC 17025 Accredited

◈ Seksyen Pengujian Produk & Kosmetik · Unit Penyaringan

PKKK/300/UP/018 Pengesanan Bahan Kawalan dan Terlarang dalam produk Tradisional menggunakan GCMS

Arahan Kerja Rasmi (Level 300 SOP) · Kategori: GC-MS
1
1. Reagen & Piawai
Penyediaan fasa bergerak, stok & kalibrasi
2
2. Pengekstrakan
Timbang, sonikasi, sentrifug & turas 0.45µm
3
3. Persediaan Alat
Purging saluran, autotune & baseline
4
4. Suntikan Batch
Blank, SST (n=6), Sampel & IQC
5
5. Verifikasi & Rekod
Padanan RT, spektrum UV/MS & Laporan
Spesifikasi & Parameter Kromatografi / Analitikal (Official Parameters):
Instrumen UtamaAgilent / Shimadzu GC-MS Systems
Turus / ColumnHP-5MS / DB-5MS (30 m × 0.25 mm × 0.25 µm)
Fasa Bergerak / PelarutHelium Gas Pembawa (Ketulenan Tinggi)
Kadar Alir & Suhu1.0 mL/min @ Oven Program: 100 °C (1 min) → 10 °C/min ke 300 °C (5 min)
Pengesan / Gelombang / SIMFull Scan EI m/z 40 – 550 amu
Kriteria Kesesuaian Sistem (SST)Padanan spektrum NIST Library Match Factor > 800, Retention Index (RI) ± 10 unit.
🎯 Sebatian Sasaran Pengujian:
DexamethasoneBetamethasonePrednisonePrednisoloneTriamcinolone acetonideHydrocortisone acetateCortisone acetateBetamethasone-17-valerate
💡 Petua & Perhatian Penting Makmal (Bench Notes):
Analyst Benchtop Checklist Progress
0 / 25 Langkah Selesai (0%)
NPRA
PUSAT KAWALAN KUALITI
ARAHAN KERJA: PENGESANAN BAHAN KAWALAN DAN TERLARANG DALAM PRODUK TRADISIONAL MENGGUNAKAN GCMS
No. Dokumen: PKKK/300/UP/018 Terbitan / Semakan: Terbitan 3 Semakan 0
Tarikh Kuatkuasa: 10 April 2026 Bahagian / Unit: SPPK · Unit Penyaringan
📋

0.0 SEJARAH PINDAAN & SEMAKAN

📋 Sejarah Pindaan & Semakan Dokumen (1 entri)

Terbitan 2, Semakan 0:

PKKK/300/HMS/023 kepada PKKK/300/UAT/005

PKKK/300/HMS/031 kepada PKKK/300/UAT/011

PKKK/300/HMS/080 kepada PKKK/300/UAT/018

PKKK/300/HMS/026 kepada PKKK/300/UAT/001

PKKK/300/HMS/070 kepada PKKK/300/UAT/014

PKKK/300/HMS/071 kepada PKKK/300/UAT/015

Menambah langkah penyediaan sampel dengan lebih terperinci di para 6.4.2

📋 Sejarah Pindaan & Semakan Dokumen (1 entri)

Terbitan 2, Semakan 1:

Memansuhkan perenggan 6.2.2 dan mengemaskini ‘Preparation of working standard solution’di perenggan 6.2.1

📋 Sejarah Pindaan & Semakan Dokumen (3 entri)

Mengemaskini penomboran di perenggan 6

Menambah 6.4.2 System Suitability Test by Tuning Evaluation

Mengemaskini Appendix A

dengan menambah nota tambahan: ‘All compounds can be detected under all pH conditions and with direct dissolution in ethanol. This appendix specifies the conditions in which each compound's peak is most prominent.’

📋 Sejarah Pindaan & Semakan Dokumen (21 entri)

mengemaskini nama komponen dan penyediaan sampel pada nombor 45 dan 64.

Terbitan 2, Semakan 2:

Mengemaskini rujukan dengan menambah Buku Manual GCMS Agilent (7890/5975C), GCMS Agilent (8890/5977B) dan GCMS Shimadzu QP2010 Ultra

Mengemaskini perenggan 6.4.2 dengan menambah tuning parameter dan kriteria untuk setiap model GCMS yang digunakan

Mengemaskini perenggan 3.0 Definisi dengan menambah SPE Solid Phase Extraction, LLE Liquid Phase Extraction, LOD Limit of Detection dan PtP Peak-to-peak

Mengemaskini Appendix A dengan menambah SPE dan LLE untuk compounds yang berkenaan dan menambah compound Ticlopidine

Mengemaskini perenggan 6.3.2 kepada When samples require pH adjustment prior to analysis, either Solid-Phase Extraction (SPE) or Liquid-Liquid Extraction (LLE) may be employed

Menambah perenggan 6.4.5 Determination of LOD dan seterusnya mengemaskini kini penomboran perenggan 6.4.6 Mass Spectrum Observation dan 6.4.7 Injection Sequence.

Terbitan 2, Semakan 3:

Mengemaskini perenggan 5.4, penolong pegawai farmasi ditukar daripada U36 / U32 kepada U7 / U6.

Mengemaskini Appendix A dengan menambah compound Terbinafine

Terbitan 2, Semakan 4:

Mengemaskini perenggan 3.Definisi

Mengemaskini perenggan 6.4.2 dengan mengemaskini parameter Relative Abundance Ion m/z 219/69 dan 502/69 (Gas Chromatography Mass Spectroscopy Agilent (8890/5977B) dan (7890/5975C) dan menambahkan spesifikasi parameter untuk Atune.

Mengemaskini perenggan 6.4.2 dengan menambahkan Table 4: Tuning Parameters and Acceptance Criteria for GCMS Systems (Shimadzu).

Mengemaskini perenggan 6.4.2 dengan menambahkan kenyataan System Verification 6.4.2.4 – 6.4.2.6.

Mengemaskini perenggan 6.4.5 dengan menambah Identification of Steroids by GCMS (6.4.5.1 – 6.4.5.3)

Mengemaskini Appendix A dengan menyatakan LLE pH 7 *(Use LLE only if SPE is not feasible) untuk kompaun Betamethasone, Dexamethasone dan Prednisolone.

Mengemaskini perenggan 6.5.7 dengan menambah Tuning Report.

Mengemaskini perengan 6.4.8 dengan menggantikan nombor jadual Table 4: Injection sequence for GCMS analysis kepada Table 5: Injection sequence for GCMS analysis

Terbitan 3, Semakan 0:

📋 Sejarah Pindaan & Semakan Dokumen (1 entri)

Kemaskini tarikh kuatkuasa dari 15 Januari 2026 kepada 10 April 2026.

PKKK/300/UAT/005 kepada PKKK/300/UP/004

PKKK/300/UAT/11 kepada PKKK/300/UP/010

PKKK/300/UAT/18 kepada PKKK/300/UP/017

PKKK/300/UAT/001 kepada PKKK/300/UP/001

PKKK/300/UAT/014 kepada PKKK/300/UP/013

PKKK/300/UAT/015 kepada PKKK/300/UP/014

📋 Sejarah Pindaan & Semakan Dokumen (1 entri)

Mengemaskini perenggan 6.4.2.1 dengan menambah conduct daily tuning.

Menambah perenggan 6.4.2.4 For qualitative screening with Agilent GCMS Systems, configure the instrument using Standard Spectra Tune rather than Autotune. This preserves standard ion-ratio targets, ensuring consistent fragmentation patterns that are crucial for reliable spectral library matching.

📋 Sejarah Pindaan & Semakan Dokumen (8 entri)

Mengemaskini perenggan 6.5.6 dengan menambah utilizing the initial sample analysis as the primary basis for reporting.

Diclofenac dan ketoprofen dikeluarkan dari senarai Appendix A

Kemaskini perenggan 3 dengan menambah definisi HP 5MS, EM, m/z, PW dan NSAIDS.

Mengemaskini Relative Abundance Ion m/z 69 untuk Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra) di Table 4: Tuning Parameters and Acceptance Criteria for GCMS Systems (Shimadzu) kepada Ratio Precursor Ion m/z 69.

Mengemaskini para 7 Rekod Kualiti dengan menambah:

UP/001A Borang Persampelan

UP/004 Laporan Pengesanan Bahan Kawalan dan Terlarang dalam produk Tradisional

menggunakan GCMS

🎯

1.0 TUJUAN

Untuk memastikan ujian pengesanan bahan terlarang dan terhad (atau bahan kawalan dan terlarang) dalam produk tradisional menggunakan alat Gas Chromatography Mass Spectrometry (GCMS) dilaksanakan dengan cekap dan berkesan.

📐

2.0 SKOP

🔬

6.0 PROSEDUR

Materials and Equipments

Instrument:

Gas Chromatography with single quadrupole Mass Spectrometry (EI)

Column:

HP 5MS 0.25µ, 30 m x 0.25 mm or equivalent

Reference standards:

Primary or secondary RS or equivalent (Refer Appendix A)

Chemical:

Ethanol

Glasswares and consumables:

Beakers

Volumetric Flasks (Grade A)

Nylon syringe filter 0.45 µm

Disposable syringe without needle (5 mL)

2 mL glass screw cap vial

Working standard solution

Sample handling (sampling)

Sampling processes differ between different types of dosage form. Please refer to the document PKKK/300/UP/001 (Proses Persampelan).

Sample preparation for analysis

The sample preparation process varies depending on the compound of interest. Three main methods are applied: Solid-Phase Extraction (SPE), Liquid-Liquid Extraction (LLE), and direct dissolved with ethanol.

When samples require pH adjustment prior to analysis, either Solid-Phase Extraction (SPE) or Liquid-Liquid Extraction (LLE) may be employed. Detailed procedures for both techniques can be found in documents PKKK/300/UP/013 and PKKK/300/UP/014.

For preparing samples by direct dissolving in Ethanol, the procedure is as follows:

Weight 1 gram of the sample (for dosage form such as capsule, powder, pill and cream) or measure 10 mL of the sample (for liquid dosage forms) into a beaker.

Experimental Method

The GCMS system used for detection of controlled and prohibited compounds in traditional products are given in Table 1 below.

Table 1: GCMS system for detection of controlled and prohibited compound

Column Temperature Program

Method apply column temperature program for detection of prohibited and restricted compound in traditional product:

Table 2: Column Temperature Program

Refer to document PKKK/300/UP/004 (GCMS Agilent 7890/5975C), PKKK/300/UP/010 (GCMS Shimadzu QP2010 Ultra), PKKK/300/UP/017 (GCMS Agilent 8890/5977B) on how to set-up temperature program and GCMS system.

System Suitability Test by Tuning Evaluation and System Verification

Conduct daily tuning using the system's built-in software to ensure the GCMS is performing optimally and capable of delivering accurate and reliable results.

The generated tuning report must meet predefined criteria for the GCMS model before proceeding with sample analysis.

Table 3: Tuning Parameters and Acceptance Criteria for GCMS Systems (Agilent).

Table 4: Tuning Parameters and Acceptance Criteria for GCMS Systems (Shimadzu)

For qualitative screening with Agilent GCMS Systems, configure the instrument using Standard Spectra Tune rather than Autotune. This preserves standard ion-ratio targets, ensuring consistent fragmentation patterns that are crucial for reliable spectral library matching.

For routine system performance verification, the Tune Evaluation function shall be performed daily (or as specified). This function is accessed in the instrument software by selecting Tune > Tune Evaluation.

Tune Evaluation automatically turns on the MS and collects the required data to generate a detailed verification report.

The report provides an automatic review and evaluation of key tune parameters, including: Mass Axis Calibration, Isotope Ratios, Precursor’s Presence, Air and Water Levels, and Multiplier Voltage. The acceptance criteria for evaluation remain consistent, irrespective of whether the system is evaluating a Standard Spectra Tune or an Autotune.

Standard Injection

Method verification is required when a compound of interest has not been tested (e.g. in a new instrument). Verification is performed by injecting a working standard solution once as assurance that the method is able to detect compounds with minimum library match at 80% in similarity. Repeat the process if library matching is less than minimum requirement or prepare a new working standard (by altering working standard concentration depending on peak intensity) if the problem is not resolved.

In the confirmation test (2nd analysis), a working standard solution is injected together during sample analysis (to ensure the system is at optimal condition with minimum library matching at 80%).

Sample Injection

The sample contains compounds if the retention time matched with reference standard and mass spectrum of the sample has minimum similarity matching with the library at 80%. No carry over from the previous sample is ensured by checking the chromatogram of diluent before sample injection (absent of compound detected).

Identification of Steroids by GCMS

Identification of Steroids by GCMS in Multi-Component Samples

Individual Analysis of Sample

If a received sample consists of different components or colours (e.g. a green capsule and a red capsule) and is requested for analysis using this GCMS screening method, each component shall be analysed individually. Sample extraction may utilize Solid-Phase Extraction (SPE) at varying pH levels (pH 3, 7, or 11), or by Direct Dissolve Ethanol, depending on the target analyte profile (e.g., SPE pH 3 for initial NSAID screening).

Re-analysis for Positive Screening Results

If one of the analysed sample components (e.g. the green capsule) detects the presence of a steroid compound (e.g. Dexamethasone) via the GCMS screening method, the second analyst is mandated to repeat the confirmatory analysis for that specific component. The repeat analysis must use the exact same extraction technique (e.g. SPE pH3) and test method as utilized by the first analyst.

Follow-up Action for Negative Screening Results

For any sample component that does not detect the target compound(s) via the initial GCMS screening method (e.g., the red capsule), or where the detected compound (e.g., Dexamethasone detected in SPE pH 3) is known to yield a LODcleaner, more definitive result using a different established extraction (e.g., SPE pH 7), that component shall then proceed to analysis using the specific steroid HPLC method (Method Reference: PKKK/300/UP/047), utilizing the SPE pH 7 extraction procedure.

This step is to ensure comprehensive screening, as the GCMS method may miss polar steroids or those less efficiently extracted at the initial screening pH (e.g., pH 3, optimized for NSAIDs). Switching to the HPLC method with the optimized extraction (SPE pH 7) provides the necessary sensitivity and selectivity for conclusive steroid detection.

Determination of Limit of Detection (LOD)

Limit of Detection (LOD) for a compound is determined using peak-to-peak (PtP) Signal-to-Noise Ratio (S/N) analysis.

Analyze the prepared solution to generate a PtP profile of the compound.

Calculate the Signal-to-Noise Ratio (S/N) from the PtP data.

LOD Calculation

The LOD concentration is calculated to achieve a minimum PtP S/N ratio of 3:1 using the formula:

LOD Concentration =

Example: For a 1 mg/mL (equivalent to 1000 ppm) Chlorpheniramine standard with a PtP S/N of 3924.65:

LOD Concentration =

= 0.76 ppm

Verification of LOD

If the PtP S/N ratio is less than 3, prepare a higher concentration and repeat the injection until the PtP S/N is at least 3.

This procedure provides a temporary LOD concentration for use in the confirmation test (2nd analysis) until method validation is completed.

Upon completion of method validation, the validated LOD will replace the temporary LOD and a new procedure will be developed accordingly.

Mass spectrum observation

To observe and check mass spectrum of the sample and reference standard, refer to document PKKK/300/UP/004 (GCMS Agilent 7890/5975C), PKKK/300/UP/010 (GCMS Shimadzu QP2010 Ultra), PKKK/300/UP/017 (GCMS Agilent 8890/5977B).

Injection Sequence

Injection of diluent (ethanol) must be performed before and after sample injection. Refer to Table 5 for example of sequence table:

Table 5: Injection sequence for GCMS analysis

Analysis report

Each sample will have one analysis report. Report must consist of detail as below:

Sample details (Sample name, sample number and batch number)

Analysis date

Equipment parameter including equipment name, mobile phase program, GCMS system and name of method file.

List and preparation procedures of reference standard use in analysis.

Sample preparation procedure and printed sample weight (for solid sample only)

Interpretation of result (Detected, Not Detected or suspected of specific compound),

utilizing the initial sample analysis as the primary basis for reporting.

Evidence of analysis must be attached together in analysis report:

Tuning Report

Chromatogram of 1st and 2nd injection of sample (with minimum information of compound name, peak area and retention time)

Chromatogram of 1st and 2nd injection of standard (with minimum information of compound name, peak area and retention time).

Library matching for mass spectrum of sample that have similar retention time with RS (contain information of similarity index and comparison of mass spectrum with RS)

📖

3.0 DEFINISI

🔀

4.0 CARTA ALIRAN

Tiada carta aliran untuk prosedur ini.

👥

5.0 TANGGUNGJAWAB

Ketua Seksyen

Memastikan prosedur ini dipatuhi semasa pengujian dijalankan

Menyemak dan mengesahkan semua laporan ujian tidak lulus yang telah disemak oleh Pegawai Farmasi termasuk laporan OOS

Ketua Unit / Pegawai Farmasi Bertanggungjawab

Memastikan prosedur ini dipatuhi semasa pengujian dijalankan

Menyemak dan mengesahkan semua laporan ujian yang telah disemak oleh Pegawai Farmasi termasuk laporan OOS

Pegawai Farmasi

Mengagihkan sampel kepada Pegawai Farmasi dan Penolong Pegawai Farmasi

Menyelia ujian yang dijalankan oleh Pegawai Farmasi dan Penolong Pegawai Farmasi

Menyemak laporan ujian

Menjalankan siasatan OOS dan menyediakan laporan OOS bagi sampel gagal ujian

Menjalankan aktiviti pengujian sampel mengikut tatacara yang telah ditetapkan

Penolong Pegawai Farmasi U7 / U6

Merekodkan bilangan ujian selepas selesai laporan ujian disiapkan untuk tujuan laporan bulanan

Menghantar laporan ujian ke Unit Perkhidmatan Analisis untuk simpanan

Menjalankan aktiviti pengujian sampel mengikut tatacara yang telah ditetapkan

📝

7. REKOD KUALITI

No. Borang Tajuk

UP/001A Borang Persampelan

UP/004 Laporan Pengesanan Bahan Kawalan dan Terlarang dalam produk

Tradisional menggunakan GCMS

APPENDIX A

Note: All compounds can be detected under all pH conditions and with direct dissolution in ethanol. This appendix specifies the conditions in which each compound's peak is most prominent.

📊

Jadual Kromatografi & Rujukan Data

SEJARAH SEMAKAN PKKK/300/UP/018
TerbitanSemakanDitulis OlehDisemak OlehDiluluskan OlehTarikh Kuatkuasa
10Nur Aziah Mohd RasaliOoi Suat HongWan Nurul Aina Mior Abdullah1 Nov 2022
20Joanne Ong Yen NeeOoi Suat HongNur Aziah Mohd Rasali1 April 2024
21Joanne Ong Yen NeeOoi Suat HongIda Syazrina Ibrahim15 Nov 2024
22Joanne Ong Yen NeeOoi Suat HongIda Syazrina Ibrahim16 Dis 2024
23Tan Lu YiOoi Suat HongIda Syazrina Ibrahim1 Julai 2025
24Tan Lu YiOoi Suat HongIda Syazrina Ibrahim15 Jan 2026
30Nurul Nadiah NohTan Lu YiIda Syazrina Ibrahim10 April 2026
JADUAL 2 PKKK/300/UP/018
RUJUKANRUJUKAN
No. DokumenTajuk
PKKK/300/UP/004Gas Chromatography-Mass Spectroscopy Agilent (7890A/5975C)
PKKK/300/UP/010Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra)
PKKK/300/UP/017Gas Chromatography-Mass Spectroscopy Agilent (8890/5977B)
PKKK/300/UP/001Proses Persampelan (Ujian Penyaringan)
PKKK/300/UP/013Pengekstrakan Fasa Pepejal Bagi Produk Tradisional, Suplemen Kesihatan dan Kosmetik
PKKK/300/UP/014Pengekstrakan Fasa Cecair Bagi Produk Tradisional, Suplemen Kesihatan dan Kosmetik
Buku Manual GCMS Agilent (7890/5975C), GCMS Agilent (8890/5977B) dan GCMS Shimadzu QP2010 Ultra
JADUAL 3 PKKK/300/UP/018
ColumnColumn
TypeHP 5MS
Dimensions30 m x 0.25 mm x 0.25µm
Mobile phaseMobile phase
TypeHelium
Gas flow rate1.0 mL/min
Gas ChromatographyGas Chromatography
Column temperatureTemperature program
Injection volume1 µL
Injection modeSplitless
Injector temperature (Front inlet)250oC
Run time32.5 minutes
Mass SpectrometryMass Spectrometry
Detector temperature
EI / MS source230oC (Max 250oC)
Quadrupole150oC (Max 200oC)
JADUAL 4 PKKK/300/UP/018
Initial TºCInitial TimeMax. TºCRun time
100oC2.00 min350oC32.5
Ramps :RateFinal TempFinal Time
20.002005.00
20.002605.00
20.002805.00
20.003105.00
JADUAL 5 PKKK/300/UP/018
GCMS ModelParametersAcceptance CriteriaAcceptance Criteria
GCMS ModelParametersStandard Spectra Tune (s.tune)Autotune (a.tune)
Gas Chromatography Mass Spectroscopy Agilent (8890/5977B) and (7890/5975C) With Tuning Standard: PFTBA (Perfluorotributylamine)Relative Abundance Ion m/z 69100%100%
Gas Chromatography Mass Spectroscopy Agilent (8890/5977B) and (7890/5975C) With Tuning Standard: PFTBA (Perfluorotributylamine)Relative Abundance Ion m/z 219/6940 - 85%70 – 150%
Gas Chromatography Mass Spectroscopy Agilent (8890/5977B) and (7890/5975C) With Tuning Standard: PFTBA (Perfluorotributylamine)Relative Abundance Ion m/z 502/692 – 5 %> 3%
Gas Chromatography Mass Spectroscopy Agilent (8890/5977B) and (7890/5975C) With Tuning Standard: PFTBA (Perfluorotributylamine)Em Volts
Gas Chromatography Mass Spectroscopy Agilent (8890/5977B) and (7890/5975C) With Tuning Standard: PFTBA (Perfluorotributylamine)Mass peak width (PW50)0.55 ± 0.10.60 ± 0.1
JADUAL 6 PKKK/300/UP/018
GCMS ModelParametersAcceptance Criteria
Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra)Full Width at half minimum (FWHM)0.5-0.7
Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra)Detector Voltage
Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra)Relative intensity ratio for m/z 502
Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra)Ratio Precursor Ion m/z 69100%
JADUAL 7 PKKK/300/UP/018
No.DetailNo. of injection
1Diluent (ethanol)1
2Sample number 12
3Diluent (ethanol)1
4Sample number 22
5Diluent (ethanol)1
6LOD (if any)1
JADUAL 8 PKKK/300/UP/018
BilCompound nameSample preparation
AlprazolamSPE pH 3, 7, 11 and Direct dissolve ethanol
Acetylsalicylic acid / aspirinSPE pH 3
AtenololDirect dissolve ethanol
AtropineSPE pH 11
BenzocaineDirect dissolve ethanol
Betamethasonei) SPE pH 7 ii) *LLE pH 7 *(Use LLE only if SPE is not feasible)
BisacodylDirect dissolve ethanol
BromhexineSPE pH 11 or Direct dissolve ethanol
BuclizineSPE pH 11 or Direct dissolve ethanol
BupropionDirect dissolve ethanol
CaffeineSPE pH 11 or Direct dissolve ethanol
CamphorDirect dissolve ethanol
CaptoprilDirect dissolve ethanol
CarbimazoleSPE pH 12
CelecoxibSPE pH 11 or direct dissolve ethanol
ChloramphenicolDirect dissolve ethanol
ChlorpheniramineSPE pH 11 or Direct dissolve ethanol
CinnarizineSPE pH 11 or Direct dissolve ethanol
CitalopramSPE pH 3, 7, 11 and Direct dissolve ethanol
ClindamycinDirect dissolve ethanol
ClotrimazoleSPE pH 3, 7, 11
CodeineDirect dissolve ethanol
ColchicineSPE pH 11 or direct dissolve ethanol
CyropheptadieneSPE pH 11 or Direct dissolve ethanol
Dexamethasonei) SPE pH 7 ii) *LLE pH 7 *(Use LLE only if SPE is not feasible)
DexchlorpheniramineSPE pH 11 or Direct dissolve ethanol
DextromethorphanSPE pH 11 or Direct dissolve ethanol
DiazepamSPE pH 3, 7, 11 and Direct dissolve ethanol
DibucaineSPE pH 11 or Direct dissolve ethanol
DimenhydrinateDirect dissolve ethanol
DiphenhydramineSPE pH 11 or Direct dissolve ethanol
DiphenoxylateSPE pH 7
EconazoleSPE pH 3, 7, 11
EphedrineSPE pH 11 or Direct dissolve ethanol
Estradiol BenzoateSPE pH 7
Ethinyl OestradiolSPE pH 7
FenfluramineSPE pH 5, 11 and Direct dissolve ethanol
FluoxetineSPE pH 3, 7, 11 and Direct dissolve ethanol
GriseofulvinSPE pH 3, 7, 11
GuaifenesinSPE pH 11 or Direct dissolve ethanol
HydroquinoneSPE pH 12 or Direct dissolve ethanol
HyoscineSPE pH 11
IbuprofenSPE pH 3
LidocaineSPE pH 11 or Direct dissolve Ethanol
LoperamideSPE pH 11
LoratadineSPE pH 11 or Direct dissolve ethanol
Mefenamic acidSPE pH 3
MentholDirect dissolve ethanol
MetoclopramideSPE pH 11
MethadoneSPE pH 11
MethamphetamineSPE pH 3, 7, 11 and Direct dissolve ethanol
MethimazoleSPE pH 12
Methyl salicylateDirect dissolve ethanol
Methyl TestosteroneSPE pH 7
MetoprololDirect dissolve ethanol
MetronidazoleDirect dissolve ethanol
MiconazoleSPE pH 3, 7, 11
MidazolamSPE pH 3, 7, 11 and Direct dissolve ethanol
MinoxidilSPE pH 3
MorphineSPE pH 11
N-desmethylsibutramineSPE pH 5, 11 and direct dissolve ethanol
NaproxenSPE pH 3
NifedipineSPE pH 3 or Direct dissolve ethanol
NicotineSPE pH 11 or Direct dissolve ethanol
NorethisteroneSPE pH 7
OrphenadrineSPE pH 11
ParacetamolSPE pH 3
PhenolphthaleinDirect dissolve ethanol
PhentermineSPE pH 5, 11 and direct dissolve ethanol
PhenylbutazoneSPE pH 3
PhenylpropanolamineSPE pH 11
Prednisolonei) SPE pH 7 ii) *LLE pH 7 *(Use LLE only if SPE is not feasible)
PrilocaineSPE pH 11 or direct dissolve Ethanol
ProchlorperazineSPE pH 11
ProgesteroneSPE pH 7
PromethazineSPE pH 11 or Direct dissolve ethanol
PseudoephedrineSPE pH 11 or Direct dissolve ethanol
SalbutamolSPE pH 11
Salicylic acidSPE pH 3
SibutramineSPE pH 5, 11 and direct dissolve ethanol
SimvastatinDirect dissolve ethanol
SulfametaxoleDirect dissolve ethanol
TadalafilSPE pH 3
TerbinafineSPE pH 3, 7, 11
TerbutalineSPE pH 11
TestosteroneSPE pH 7
Testosterone PropionateSPE pH 7
TetracaineSPE pH 11 or Direct dissolve ethanol
TetrahydrozolineDirect dissolve ethanol
TheophyllineSPE pH 11
ThymolDirect dissolve ethanol
TiclopidineSPE pH 11
TramadolSPE pH 11
TrimethoprimDirect dissolve ethanol
YohimbineDirect dissolve ethanol